{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:53:55Z","timestamp":1761807235814},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.bbrc.2006.03.135","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T07:14:41Z","timestamp":1143789281000},"page":"463-470","source":"Crossref","is-referenced-by-count":9,"title":["Interactions of recombinant prions with compounds of therapeutical significance"],"prefix":"10.1016","volume":"344","author":[{"given":"Dessislava","family":"Georgieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schwark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"von Bergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Redecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolay","family":"Genov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Betzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2006.03.135_bib1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions (Nobel Lecture)","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00019052-199508000-00007","article-title":"Human prion diseases","volume":"8","author":"Parchi","year":"1995","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbrc.2006.03.135_bib3","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1073\/pnas.97.15.8334","article-title":"NMR structure of the bovine prion protein","volume":"97","author":"Garcia","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt\u2013Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2006.03.135_bib5","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1074\/jbc.M110197200","article-title":"Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases","volume":"277","author":"Lorenz","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib6","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1073\/pnas.96.5.2042","article-title":"Copper binding to the prion protein: structural implications of four identical cooperative binding sites","volume":"96","author":"Viles","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib7","doi-asserted-by":"crossref","first-page":"33107","DOI":"10.1074\/jbc.273.50.33107","article-title":"Copper stimulates endocytosis of the prion protein","volume":"273","author":"Pauly","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib8","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1074\/jbc.M211830200","article-title":"Expression of prion protein increases cellular copper binding and antioxidant enzyme activitiy but not copper delivery","volume":"278","author":"Rachidi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib9","doi-asserted-by":"crossref","first-page":"46199","DOI":"10.1074\/jbc.C300303200","article-title":"Copper helation delays the onset of prion disease","volume":"278","author":"Sigurdsson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(97)01330-6","article-title":"Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding","volume":"417","author":"Zahn","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2006.03.135_bib11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbrc.2004.08.230","article-title":"Oligomerization of the proteolytic products is an intrinsic property of prion proteins","volume":"323","author":"Georgieva","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2006.03.135_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj2070193","article-title":"Chemical photochemical and spectroscopic characterization of an alkaline proteinase from Bacillus subtilis variant DY","volume":"207","author":"Genov","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2006.03.135_bib13","first-page":"431","article-title":"On the composition of the enzyme preparation E-30 \u2013 characteristics of the proteolitic enzymes in it","volume":"23","author":"Karadjova","year":"1970","journal-title":"Compt. Rend. Bulg. Acad. Sci."},{"key":"10.1016\/j.bbrc.2006.03.135_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.299.5604.191","article-title":"Prion disease treatment\u2019s early promise unravels","volume":"299","author":"Follette","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2006.03.135_bib15","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","article-title":"Evaluation of quinacrine treatment for prion diseases","volume":"77","author":"Barret","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2006.03.135_bib16","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000076350","article-title":"Results of quinacrine administration to patients with Creutzfeldt\u2013Jakob disease","volume":"17","author":"Nakajima","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbrc.2006.03.135_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/JVI.78.3.1281-1288.2004","article-title":"Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies","volume":"78","author":"Murakami-Kubo","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2006.03.135_bib19","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1002\/j.1460-2075.1996.tb01027.x","article-title":"Chemical chaperones interfere with the formation of scrapie prion protein","volume":"15","author":"Tatzelt","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2006.03.135_bib20","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib21","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1073\/pnas.95.21.12580","article-title":"Doxycycline control of prion protein transgene expression modulates prion disease in mice","volume":"95","author":"Tremblay","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2885.2003.00525.x","article-title":"Emerging therapeutic agents for transmissible spongiform encephalopathies: a review","volume":"26","author":"Koster","year":"2003","journal-title":"J. Veter. Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2006.03.135_bib23","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1021\/jm049922t","article-title":"Synthesis of analogues of Congo red and evaluation of their anti-prion activity","volume":"47","author":"Sellarajah","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib24","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/jm034093h","article-title":"Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein","volume":"46","author":"Vogther","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2006.03.135_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.97.1.145","article-title":"NMR solution structure of the human prion protein","volume":"97","author":"Zahn","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.03.135_bib26","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.94.19.10086","article-title":"Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform","volume":"94","author":"James","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06006826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06006826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T02:35:53Z","timestamp":1549593353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X06006826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0006291X06006826"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2006.03.135","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}